FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for EQUETRO (carbamazepine) submitted by Validus Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy
• Trigeminal Neuralgia

Drugs mentioned

• EQUETRO (CARBAMAZEPINE)

Snippet

SUPPL AP for EQUETRO (CARBAMAZEPINE)